New Results
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
Venexia M Walker, George Davey Smith, Neil M Davies, Richard M Martin
doi: https://doi.org/10.1101/105338
Venexia M Walker
1School of Social and Community Medicine, University of Bristol, United Kingdom
2MRC University of Bristol Integrative Epidemiology Unit, United Kingdom
George Davey Smith
1School of Social and Community Medicine, University of Bristol, United Kingdom
2MRC University of Bristol Integrative Epidemiology Unit, United Kingdom
Neil M Davies
1School of Social and Community Medicine, University of Bristol, United Kingdom
2MRC University of Bristol Integrative Epidemiology Unit, United Kingdom
Richard M Martin
1School of Social and Community Medicine, University of Bristol, United Kingdom
2MRC University of Bristol Integrative Epidemiology Unit, United Kingdom
Article usage
Posted February 02, 2017.
Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities
Venexia M Walker, George Davey Smith, Neil M Davies, Richard M Martin
bioRxiv 105338; doi: https://doi.org/10.1101/105338
Subject Area
Subject Areas
- Biochemistry (11739)
- Bioengineering (8750)
- Bioinformatics (29189)
- Biophysics (14967)
- Cancer Biology (12093)
- Cell Biology (17409)
- Clinical Trials (138)
- Developmental Biology (9419)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18301)
- Genetics (12238)
- Genomics (16797)
- Immunology (11865)
- Microbiology (28068)
- Molecular Biology (11583)
- Neuroscience (60953)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4957)
- Plant Biology (10425)
- Synthetic Biology (2884)
- Systems Biology (7338)
- Zoology (1651)